About

Business Strategy

We work with our partners across the research & development value chain and clinical field.
Our Unique iDXGate Solution that we generate provides valuable insights to inform and accelerate preclinical and clinical drug development, also decision of treatment regimen potentially saving significant cost and time.

01 iDXGate SN Immune diagnostics
development service

  • Development of disease—specific serum biomarkers
  • DeveIopment of monoclonal antibodies based on biomarkers
  • Application testing on diagnostic platforms
  • Rapid Kit and IVD-MIA (ln Vitro Diagnostics Multivariate lndex Assay)
    development services.

02 iDXGate TO Targeted Oncology CDx service

  • Development of cancer—specific mutation markers
  • CTC (Circulating Tumor CeII) based drug efficacy monitoring service
  • DeveIopment of CTC-based response prediction algorithms
  • Application testing on diagnostic platforms
  • Companion Diagnosis clinical research and development services.

03 iDXGate IO Immuno Oncology CDx service

  • Development of cancer—specific immune biomarkers.
  • T cell-based drug efficacy monitoring service.
  • Development of T cell-based response prediction algorithms.
  • Application testing on diagnostic platforms.
  • Companion Diagnosis clinical research and development services.

04 OncoProfiler Integrated analysis service
based on Liquid Biopsy

  • lntegrated analysis testing for CTC (circulating Tumor cells) which includes CTC IF (lmmunofluorescence), enumeration, genome profiling, and comprehensive analysis.
  • lntegrated genomic analysis service for ctDNA (circulating tumor DNA), CTC, and tissue samples, including comparative characterization and mechanism of metastasis research.
  • scRNA (single-cell RNA) sequencing analysis service based on Any-Hold technology.
  • T cell-based TCR (T-ceII receptor) repertoire analysis service using iCLUST technology.